Marius Pharmaceuticals Announces Launch of Marius AI, Positioning the Company as the First AI-Native Pharmaceutical Company

madman

Super Moderator

Raleigh, N.C., (May 7th, 2026) – Marius Pharmaceuticals, Inc., the makers of KYZATREX® (testosterone undecanoate) CIII Capsules, today announced a significant expansion of its leadership team and advisory board, alongside the launch of Marius AI — a bold initiative that positions Marius as the first AI-native pharmaceutical company in the industry.

These additions reflect Marius’s continued investment in building a high-performance team and advancing its mission to transform the standard of care in men’s health.
 
 

ExcelMale Newsletter Signup

Online statistics

Members online
4
Guests online
289
Total visitors
293

Latest posts

Beyond Testosterone Podcast

Back
Top